Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1990 | |
| Cash Flows From Operating Activities | |
| Net Income | -287 |
| Depreciation Amortization | 4 |
| Other Working Capital | -10 |
| Other Operating Activity | 1 |
| Operating Cash Flow | $-292 |
| Cash Flows From Investing Activities | |
| PPE Investments | -35 |
| Investing Cash Flow | $-35 |
| Cash Flows From Financing Activities | |
| Other Financing Activity | 374 |
| Financing Cash Flow | $374 |
| End Cash Position | 47 |
| Net Cash Flow | $47 |
| Free Cash Flow | |
| Operating Cash Flow | -292 |
| Free Cash Flow | -292 |